Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.

Gautam, RK; Mittal, P; Goyal, R; Dua, K; Mishra, DK; Sharma, S; Singla, RK

Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.

Gautam, RK Mittal, P Goyal, R Dua, K

Mishra, DK Sharma, S Singla, RK

Permalink

Publisher:: Bentham Science Publishers
Publication Type:: Journal Article
Citation:: Curr Med Chem, 2023, 31
Issue Date:: 2023-10-11

Closed Access

	Filename	Description	Size
	Nanomedicine_Targeted Cancer Thearpy.pdf	Accepted version	1.5 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Gautam, RK
dc.contributor.author	Mittal, P
dc.contributor.author	Goyal, R
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.contributor.author	Mishra, DK
dc.contributor.author	Sharma, S
dc.contributor.author	Singla, RK
dc.date.accessioned	2023-11-25T06:21:36Z
dc.date.available	2023-08-17
dc.date.available	2023-11-25T06:21:36Z
dc.date.issued	2023-10-11
dc.identifier.citation	Curr Med Chem, 2023, 31
dc.identifier.issn	0929-8673
dc.identifier.issn	1875-533X
dc.identifier.uri	http://hdl.handle.net/10453/173550
dc.description.abstract	Nanomedicine's application of nanotechnology in medicine holds tremendous potential for diagnosing and treating life-threatening diseases such as cancer. Unlike conventional therapies, nanomedicine offers a promising strategy to enhance clinical outcomes while minimizing severe side effects. The principle of drug targeting enables specific delivery of therapeutic agents to their intended sites, making it a more precise and effective therapy. Combination strategies, such as the co-delivery of chemotherapeutic drugs with nucleic acids or receptor-specific molecules, are being employed to enhance therapeutic outcomes. Nanocarriers and drug delivery systems designed using these approaches offer resourceful co-delivery of therapeutic agents for anticancer therapy. Targeted drug delivery via nanotechnology-based techniques has become an urgent need and has shown significant improvements in therapeutic implications, pharmacokinetics, specificity, reduced toxicity, and biocompatibility. This review discusses the extrapolation of nanomaterials for developing innovative and novel drug delivery systems for effective anticancer therapy. Additionally, we explore the role of nanotechnology-based concepts in drug delivery research.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	Bentham Science Publishers
dc.relation.ispartof	Curr Med Chem
dc.relation.isbasedon	10.2174/0109298673258987231004092334
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	0304 Medicinal and Biomolecular Chemistry, 0601 Biochemistry and Cell Biology, 1115 Pharmacology and Pharmaceutical Sciences
dc.subject.classification	Medicinal & Biomolecular Chemistry
dc.subject.classification	3214 Pharmacology and pharmaceutical sciences
dc.subject.classification	3404 Medicinal and biomolecular chemistry
dc.title	Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
dc.type	Journal Article
utslib.citation.volume	31
utslib.location.activity	United Arab Emirates
utslib.for	0304 Medicinal and Biomolecular Chemistry
utslib.for	0601 Biochemistry and Cell Biology
utslib.for	1115 Pharmacology and Pharmaceutical Sciences
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	closed_access	*
dc.date.updated	2023-11-25T06:21:35Z
pubs.publication-status	Published online
pubs.volume	31

Abstract:

Nanomedicine's application of nanotechnology in medicine holds tremendous potential for diagnosing and treating life-threatening diseases such as cancer. Unlike conventional therapies, nanomedicine offers a promising strategy to enhance clinical outcomes while minimizing severe side effects. The principle of drug targeting enables specific delivery of therapeutic agents to their intended sites, making it a more precise and effective therapy. Combination strategies, such as the co-delivery of chemotherapeutic drugs with nucleic acids or receptor-specific molecules, are being employed to enhance therapeutic outcomes. Nanocarriers and drug delivery systems designed using these approaches offer resourceful co-delivery of therapeutic agents for anticancer therapy. Targeted drug delivery via nanotechnology-based techniques has become an urgent need and has shown significant improvements in therapeutic implications, pharmacokinetics, specificity, reduced toxicity, and biocompatibility. This review discusses the extrapolation of nanomaterials for developing innovative and novel drug delivery systems for effective anticancer therapy. Additionally, we explore the role of nanotechnology-based concepts in drug delivery research.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/173550